{{Rsnum
|rsid=2052129
|Gene=ABP1
|Chromosome=7
|position=150851884
|Orientation=plus
|GMAF=0.1947
|Gene_s=ABP1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 6.2 | 40.7 | 53.1
| HCB | 0.7 | 25.5 | 73.7
| JPT | 0.9 | 15.9 | 83.2
| YRI | 7.5 | 38.8 | 53.7
| ASW | 3.5 | 47.4 | 49.1
| CHB | 0.7 | 25.5 | 73.7
| CHD | 0.9 | 22.0 | 77.1
| GIH | 6.9 | 19.8 | 73.3
| LWK | 2.7 | 26.4 | 70.9
| MEX | 1.7 | 31.0 | 67.2
| MKK | 0.0 | 11.5 | 88.5
| TSI | 8.8 | 30.4 | 60.8
| HapMapRevision=28
}}{{PMID|21488903}} Association of single nucleotide polymorphisms in the diamine oxidase gene with diamine oxidase serum activities. Found reduced DAO activity for the minor allele, lower promoter activity for the minor allele and lower DAO mRNA expression for the homozygous minor allele.

{{PMID Auto
|PMID=23152756
|Title=The Diamine Oxidase Gene Is Associated with Hypersensitivity Response to Non-Steroidal Anti-Inflammatory Drugs
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}